Search

Your search keyword '"Samai, Mohamed"' showing total 285 results

Search Constraints

Start Over You searched for: Author "Samai, Mohamed" Remove constraint Author: "Samai, Mohamed" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
285 results on '"Samai, Mohamed"'

Search Results

1. An intra-covid-19 assessment of hand hygiene facility, policy and staff compliance in two hospitals in Sierra Leone: Is there a difference between regional and capital city hospitals?

3. Coverage of intermittent preventive treatment of malaria in infants after four years of implementation in Sierra Leone

4. Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone

6. Prevalence of immunoglobulin G and M to SARS-CoV-2 and other human coronaviruses in The Democratic Republic of Congo, Sierra Leone, and Uganda: A longitudinal study

7. Immune response of a two-dose heterologous Ebola vaccine regimen: summary of three African clinical trials using a single validated Filovirus Animal Nonclinical Group enzyme-linked immunosorbent assay in a single accredited laboratory

8. Safety and immunogenicity of an Ad26.ZEBOV booster dose in children previously vaccinated with the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen: an open-label, non-randomised, phase 2 trial

9. Incidence and risk factors of surgical site infections and related antibiotic resistance in Freetown, Sierra Leone: a prospective cohort study

11. Impact of oral azithromycin and intermittent preventive treatment with sulfadoxine-pyrimethamine regimen on child mortality in Sierra Leone: trial protocol for a randomised, two-arm, double-blinded, placebo-controlled clinical trial (ICARIA).

12. Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial

13. Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial

14. An Assessment of Medication Errors Among Pediatric Patients in Three Hospitals in Freetown Sierra Leone: Findings and Implications for a Low-Income Country

16. Immunisation coverage and factors associated with incomplete immunisation in children under two during the COVID-19 pandemic in Sierra Leone

17. An Assessment of Medication Errors Among Pediatric Patients in Three Hospitals in Freetown Sierra Leone: Findings and Implications for a Low-Income Country

18. Immunisation coverage and factors associated with incomplete immunisation in children under two during the COVID-19 pandemic in Sierra Leone

19. PA-605 Acceptability and feasibility of perennial malaria chemoprevention for children under two years: a mixed method pre-implementation assessment in Togo (MULTIPLY project)

20. PA-566 Acceptability and feasibility of a pilot malaria prevention strategy for children under two years in Sierra Leone: a mixed methods study among health care workers

21. PA-466 Factors associated with coverage of three doses of intermittent preventive treatment of malaria in infants with Sulfadoxine-pyrimethamine: a cross-sectional community-based survey in Sierra Leone

22. PA-574 Prevalence and factors associated with malaria infection in children aged 10 to 23 months in Togo in 2022

23. Pregnancy Outcomes among Women Receiving rVSV[DELTA]-ZEBOV-GP Ebola Vaccine during the Sierra Leone Trial to Introduce a Vaccine against Ebola

24. Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone

25. The Sierra Leone Trial to Introduce a Vaccine Against Ebola : An Evaluation of rVSVΔG-ZEBOV-GP Vaccine Tolerability and Safety During the West Africa Ebola Outbreak

27. Monitoring Serious Adverse Events in the Sierra Leone Trial to Introduce a Vaccine Against Ebola

28. Health Conditions in an Adult Population in Sierra Leone : Data Reported From the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE)

30. Implementing a Multisite Clinical Trial in the Midst of an Ebola Outbreak : Lessons Learned From the Sierra Leone Trial to Introduce a Vaccine Against Ebola

31. Clinical Surveillance and Evaluation of Suspected Ebola Cases in a Vaccine Trial During an Ebola Epidemic : The Sierra Leone Trial to Introduce a Vaccine Against Ebola

34. Novel superoxide dismutase mimetics for protection against paraquat nephrotoxicity

35. The Effect of Previous Exposure to Malaria Infection and Clinical Malaria Episodes on the Immune Response to the Two-Dose Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen

36. African Medicines Agency: How it will change the landscape of medicines in Africa

40. Top 10 public health challenges to track in 2023: Shifting focus beyond a global pandemic

41. Prevalence of IgG and IgM to SARS-CoV-2 and other human coronaviruses in The Democratic Republic of Congo, Sierra Leone and Uganda: A Longitudinal Study

42. Additional file 2 of Coverage of intermittent preventive treatment of malaria in infants after four years of implementation in Sierra Leone

43. Additional file 1 of Coverage of intermittent preventive treatment of malaria in infants after four years of implementation in Sierra Leone

44. Randomized Trial of Vaccines for Zaire Ebola Virus Disease

46. The monkeypox virus: A public health challenge threatening Africa

49. Prevalence of malaria and helminth infections in rural communities in northern Sierra Leone, a baseline study to inform Ebola vaccine study protocols

50. Hepatitis B Virus and Tuberculosis Are Associated with Increased Noncommunicable Disease Risk among Treatment-Naïve People with HIV: Opportunities for Prevention, Early Detection and Management of Comorbidities in Sierra Leone

Catalog

Books, media, physical & digital resources